Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118253697> ?p ?o ?g. }
- W2118253697 endingPage "1930" @default.
- W2118253697 startingPage "1926" @default.
- W2118253697 abstract "The current treatment regimes for patients with nephrotic syndrome due to idiopathic membranous nephropathy (MN) and focal segmental glomerulosclerosis (FSGS) are based on steroids and/or cytotoxic agents. Data on the effect of mycophenolate mofetil (MMF) for these conditions are scarce and confounding.We compared the efficacy of an MMF-based therapy with standard therapies in inducing remission in adult nephrotics with MN and FSGS in a randomized pilot study. MMF was given at 2 g/day for 6 months along with prednisolone at 0.5 mg/kg/day for 2-3 months. Conventional therapy was prednisolone 1 mg/kg/day for 3-6 months for FSGS and alternating monthly cycles of steroids and cyclophosphamide for 6 months for MN. The primary end point was change in urinary protein/creatinine ratio.A total of 54 patients (21 MN and 33 FSGS) were recruited; 28 were randomized to receive MMF (group A) and 26 were on conventional treatment (group B). There was no difference in the proportion of patients achieving remission in two groups (64 and 80% in MN and 70 and 69% in FSGS). The frequency of relapses and incidence of infections was also similar. FSGS patients in group A achieved remission faster and received a lower cumulative steroid dose.A 6-month treatment with MMF is as effective as the conventional treatment for primary treatment of MN and FSGS in the short term. It induces remission faster and reduces steroid exposure in FSGS patients. Studies with more cases and longer follow-up are required to evaluate its impact on preservation of kidney function." @default.
- W2118253697 created "2016-06-24" @default.
- W2118253697 creator A5005575613 @default.
- W2118253697 creator A5010273437 @default.
- W2118253697 creator A5036931186 @default.
- W2118253697 creator A5068622389 @default.
- W2118253697 creator A5071257048 @default.
- W2118253697 creator A5074210283 @default.
- W2118253697 creator A5074250606 @default.
- W2118253697 creator A5077764269 @default.
- W2118253697 date "2008-03-07" @default.
- W2118253697 modified "2023-10-16" @default.
- W2118253697 title "Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study" @default.
- W2118253697 cites W1963948820 @default.
- W2118253697 cites W1965027735 @default.
- W2118253697 cites W1975346164 @default.
- W2118253697 cites W1980836240 @default.
- W2118253697 cites W1981656965 @default.
- W2118253697 cites W1991441433 @default.
- W2118253697 cites W1993484566 @default.
- W2118253697 cites W2005367998 @default.
- W2118253697 cites W2011665041 @default.
- W2118253697 cites W2018726092 @default.
- W2118253697 cites W2042282968 @default.
- W2118253697 cites W2044471513 @default.
- W2118253697 cites W2054404003 @default.
- W2118253697 cites W2059769088 @default.
- W2118253697 cites W2073033781 @default.
- W2118253697 cites W2081272458 @default.
- W2118253697 cites W2090231740 @default.
- W2118253697 cites W2107034113 @default.
- W2118253697 cites W2108527191 @default.
- W2118253697 cites W2116986363 @default.
- W2118253697 cites W2127974063 @default.
- W2118253697 cites W2137276272 @default.
- W2118253697 cites W2153652747 @default.
- W2118253697 cites W2157375976 @default.
- W2118253697 cites W2160773404 @default.
- W2118253697 cites W2167411080 @default.
- W2118253697 cites W2244854557 @default.
- W2118253697 cites W2317837133 @default.
- W2118253697 cites W2325297572 @default.
- W2118253697 cites W2326202408 @default.
- W2118253697 cites W2441193572 @default.
- W2118253697 doi "https://doi.org/10.1093/ndt/gfm538" @default.
- W2118253697 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17989103" @default.
- W2118253697 hasPublicationYear "2008" @default.
- W2118253697 type Work @default.
- W2118253697 sameAs 2118253697 @default.
- W2118253697 citedByCount "83" @default.
- W2118253697 countsByYear W21182536972012 @default.
- W2118253697 countsByYear W21182536972013 @default.
- W2118253697 countsByYear W21182536972014 @default.
- W2118253697 countsByYear W21182536972015 @default.
- W2118253697 countsByYear W21182536972016 @default.
- W2118253697 countsByYear W21182536972017 @default.
- W2118253697 countsByYear W21182536972018 @default.
- W2118253697 countsByYear W21182536972019 @default.
- W2118253697 countsByYear W21182536972020 @default.
- W2118253697 countsByYear W21182536972021 @default.
- W2118253697 countsByYear W21182536972022 @default.
- W2118253697 countsByYear W21182536972023 @default.
- W2118253697 crossrefType "journal-article" @default.
- W2118253697 hasAuthorship W2118253697A5005575613 @default.
- W2118253697 hasAuthorship W2118253697A5010273437 @default.
- W2118253697 hasAuthorship W2118253697A5036931186 @default.
- W2118253697 hasAuthorship W2118253697A5068622389 @default.
- W2118253697 hasAuthorship W2118253697A5071257048 @default.
- W2118253697 hasAuthorship W2118253697A5074210283 @default.
- W2118253697 hasAuthorship W2118253697A5074250606 @default.
- W2118253697 hasAuthorship W2118253697A5077764269 @default.
- W2118253697 hasBestOaLocation W21182536971 @default.
- W2118253697 hasConcept C126322002 @default.
- W2118253697 hasConcept C126894567 @default.
- W2118253697 hasConcept C141071460 @default.
- W2118253697 hasConcept C2775946357 @default.
- W2118253697 hasConcept C2776694085 @default.
- W2118253697 hasConcept C2776715498 @default.
- W2118253697 hasConcept C2776755627 @default.
- W2118253697 hasConcept C2777747828 @default.
- W2118253697 hasConcept C2778415529 @default.
- W2118253697 hasConcept C2778930706 @default.
- W2118253697 hasConcept C2779561371 @default.
- W2118253697 hasConcept C2780091579 @default.
- W2118253697 hasConcept C2780306776 @default.
- W2118253697 hasConcept C71924100 @default.
- W2118253697 hasConcept C90924648 @default.
- W2118253697 hasConceptScore W2118253697C126322002 @default.
- W2118253697 hasConceptScore W2118253697C126894567 @default.
- W2118253697 hasConceptScore W2118253697C141071460 @default.
- W2118253697 hasConceptScore W2118253697C2775946357 @default.
- W2118253697 hasConceptScore W2118253697C2776694085 @default.
- W2118253697 hasConceptScore W2118253697C2776715498 @default.
- W2118253697 hasConceptScore W2118253697C2776755627 @default.
- W2118253697 hasConceptScore W2118253697C2777747828 @default.
- W2118253697 hasConceptScore W2118253697C2778415529 @default.
- W2118253697 hasConceptScore W2118253697C2778930706 @default.
- W2118253697 hasConceptScore W2118253697C2779561371 @default.